Sanofi India Q3'26 Results: Net Profit Surges 53.6% YoY; ₹75 Interim Dividend Declared
Sanofi India Ltd · Dividend · 30 Oct 2026, 12:15 am
Sanofi India Q3'26 Results: Net Profit Surges 53.6% YoY; ₹75 Interim Dividend Declared Sanofi India reported a 3.4% YoY rise in revenue from operations to ₹4,917 million for Q3 ended 30th Sep'26. Net profit surged 53.6% YoY to ₹1,167 million, aided by an 8% drop in operating expenses, favorable mix, and a low base with past exceptional costs. PBT before exceptionals grew 21.7% YoY to ₹1,577 million. Performance was led by 9% growth in the diabetes insulin portfolio (55% market share). The board declared an interim dividend of ₹75 per share, with record date fixed as 5th Nov'26.
Original exchange filing (PDF)
More announcements from Sanofi India Ltd
- Kindly refer the attachment · 18 Nov 2026
- Kindly refer the attachment · 30 Oct 2026
- Kindly refer the attachment · 30 Oct 2026
- Kindly refer the attachment · 30 Oct 2026
- Kindly refer the attachment · 30 Oct 2026
- Kindly refer the attachment · 30 Oct 2026
- Sanofi India Limited has submitted to the Exchange, the unaudited financial results for the quarter and nine months ended 30th September 2026. · 29 Oct 2026
- Kindly refer the attachment · 29 Oct 2026
